← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 10, 2019Last known activity
Aug 10, 2019
Timeline
2000s
- Jan 1, 2006
Thrombolytic Science International— Founded
Drugs by trial phase (2 distinct, 1 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (1)
- NCT04256473CollaboratorPhase 2Aug 10, 2019
Details
- Founded
- Cambridge, MA, US Jan 1, 2006
- Last known activity
- Aug 10, 2019